Fujian Wanchen Biotechnology Co. Ltd (300972) - Total Liabilities

Latest as of March 2026: CN¥7.34 Billion CNY ≈ $1.07 Billion USD

Based on the latest financial reports, Fujian Wanchen Biotechnology Co. Ltd (300972) has total liabilities worth CN¥7.34 Billion CNY (≈ $1.07 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 300972 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Fujian Wanchen Biotechnology Co. Ltd - Total Liabilities Trend (2019–2025)

This chart illustrates how Fujian Wanchen Biotechnology Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Fujian Wanchen Biotechnology Co. Ltd total assets.

Fujian Wanchen Biotechnology Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Fujian Wanchen Biotechnology Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Hengdian Group DMEGC Magnetics Co Ltd SHE:002056	China	CN¥14.86 Billion
Rail Vikas Nigam Limited NSE:RVNL	India	Rs101.92 Billion
Sonoco Products Company NYSE:SON	USA	$7.48 Billion
Nexstar Broadcasting Group Inc NASDAQ:NXST	USA	$15.47 Billion
Celanese Corporation NYSE:CE	USA	$16.82 Billion
Crocs Inc NASDAQ:CROX	USA	$2.92 Billion
Ajanta Pharma Limited NSE:AJANTPHARM	India	Rs13.57 Billion
SIG Combibloc Group AG SW:SIGN	Switzerland	CHF4.41 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Fujian Wanchen Biotechnology Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 300972 equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.64	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.68	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Fujian Wanchen Biotechnology Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)

The table below shows the annual total liabilities of Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥7.50 Billion ≈ $1.10 Billion	+29.43%
2024-12-31	CN¥5.79 Billion ≈ $847.56 Million	+79.35%
2023-12-31	CN¥3.23 Billion ≈ $472.58 Million	+510.75%
2022-12-31	CN¥528.79 Million ≈ $77.38 Million	+151.24%
2021-12-31	CN¥210.47 Million ≈ $30.80 Million	-18.40%
2020-12-31	CN¥257.94 Million ≈ $37.74 Million	-17.01%
2019-12-31	CN¥310.81 Million ≈ $45.48 Million	--

About Fujian Wanchen Biotechnology Co. Ltd

SHE:300972 China Farm Products

Market Cap

$4.82 Billion

CN¥32.93 Billion CNY

Market Cap Rank

#3660 Global

#510 in China

Share Price

CN¥169.54

Change (1 day)

+0.27%

52-Week Range

CN¥166.10 - CN¥232.89

All Time High

CN¥232.89